Sudhir Kumar Chauhan
- Researcher; PhD
Publications 2024
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
J Immunother Cancer, 12 (1)
DOI 10.1136/jitc-2023-007990, PubMed 38242720
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation
NPJ Breast Cancer, 10 (1), 30
DOI 10.1038/s41523-024-00638-2, PubMed 38653982
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival
Oncoimmunology, 14 (1), 2440967
DOI 10.1080/2162402X.2024.2440967, PubMed 39703053
Publications 2023
Human small intestine contains 2 functionally distinct regulatory T-cell subsets
J Allergy Clin Immunol, 152 (1), 278-289.e6
DOI 10.1016/j.jaci.2023.02.030, PubMed 36893861
Innate Immune Mechanism of Neutrophil Extracellular Trap Formation is Impaired in at-Risk Term Low Birth Weight Newborns
Pediatr Hematol Oncol, 40 (6), 568-586
DOI 10.1080/08880018.2023.2218409, PubMed 37288796
Dynamics of circulating lymphocytes responding to human experimental enterotoxigenic Escherichia coli infection
Eur J Immunol, 53 (8), e2250254
DOI 10.1002/eji.202250254, PubMed 37102399
Publications 2022
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Nat Med, 28 (12), 2573-2583
DOI 10.1038/s41591-022-02126-1, PubMed 36482103
Publications 2020
CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile
Mucosal Immunol, 14 (2), 402-410
DOI 10.1038/s41385-020-0315-5, PubMed 32572129
Publications 2019
Resident memory CD8 T cells persist for years in human small intestine
J Exp Med, 216 (10), 2412-2426
DOI 10.1084/jem.20190414, PubMed 31337737
Publications 2016
Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease
PLoS One, 11 (3), e0152063
DOI 10.1371/journal.pone.0152063, PubMed 27019109
RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities
PLoS One, 11 (11), e0166312
DOI 10.1371/journal.pone.0166312, PubMed 27835693
Publications 2015
Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities
Immunol Lett, 168 (2), 254-9
DOI 10.1016/j.imlet.2015.09.016, PubMed 26434792
Heat shock protein 27 and its regulatory molecules express differentially in SLE patients with distinct autoantibody profiles
Immunol Lett, 164 (1), 25-32
DOI 10.1016/j.imlet.2015.01.007, PubMed 25655337
Publications 2014
Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities
J Clin Immunol, 34 (4), 491-503
DOI 10.1007/s10875-014-0008-5, PubMed 24659206
Decreased toll-like receptor-4/myeloid differentiation factor 88 response leads to defective interleukin-1β production in term low birth weight newborns
Pediatr Infect Dis J, 33 (12), 1270-6
DOI 10.1097/INF.0000000000000416, PubMed 25389708
Publications 2013
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation
J Clin Immunol, 33 (5), 954-64
DOI 10.1007/s10875-013-9887-0, PubMed 23564191
Potential antianxiety activity of Fumaria indica: A preclinical study
Pharmacogn Mag, 9 (33), 14-22
DOI 10.4103/0973-1296.108129, PubMed 23661988
Decreased pattern recognition receptor signaling, interferon-signature, and bactericidal/permeability-increasing protein gene expression in cord blood of term low birth weight human newborns
PLoS One, 8 (4), e62845
DOI 10.1371/journal.pone.0062845, PubMed 23626859
Publications 2011
Fumaria indica is safe during chronic toxicity and cytotoxicity: A preclinical study
J Pharmacol Pharmacother, 2 (3), 191-2
DOI 10.4103/0976-500X.83287, PubMed 21897716